Empagliflozin in Patients with Chronic Kidney Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Empagliflozin in Patients with Chronic Kidney Disease

Published:2023-01-12 Issue:2 Volume:388 Page:117-127
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Funder

Boehringer Ingelheim

Eli Lilly and Company

NIHR Biomedical Centre, Oxford

Health Data Research

Medical Research Council

Kidney Research UK

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa2204233

Reference24 articles.

1. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis

2. Chronic Kidney Disease

3. Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

4. Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

5. The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic Nephropathy

Cited by 974 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inibidores de SGLT2 e inflamassoma NLRP3: alvo potencial na doença renal do diabetes;Brazilian Journal of Nephrology;2024-12

2. SGLT2 inhibitors and NLRP3 inflammasome: potential target in diabetic kidney disease;Brazilian Journal of Nephrology;2024-12

3. Effects on calcium phosphate homeostasis after sodium-glucose cotransporter 2 inhibitor in patients with advanced chronic kidney disease and type 2 diabetes mellitus;Diabetes Research and Clinical Practice;2024-10

4. DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases;Metabolism;2024-10

5. The Impact of Empagliflozin on Renal Function and Kidney Injury Markers in Patients with Diabetic Nephropathy;Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 );2024-09-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3